Abstract
PURPOSEMET exon 14 skipping alterations (METex14) comprise a diverse set of actionable oncogene drivers in non–small-cell lung cancer (NSCLC). Recent studies have established the efficacy of tyrosi...
Cite
CITATION STYLE
APA
Le, X., Hong, L., Hensel, C., Chen, R., Kemp, H., Coleman, N., … Heymach, J. V. (2021). Landscape and Clonal Dominance of Co-occurring Genomic Alterations in Non–Small-Cell Lung Cancer Harboring MET Exon 14 Skipping. JCO Precision Oncology, (5), 1802–1812. https://doi.org/10.1200/po.21.00135
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free